Concepedia

Publication | Open Access

Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study

DOIFull Paper Access

60

Citations

19

References

2014

Year

Kohei Kaku, Hiroshi Maegawa, Yukio Tanizawa, Arihiro Kiyosue, Yumiko Ide, Takuto Tokudome, Yuji Hoshino, Yang JISIN, Anna Maria Langkilde
Diabetes Therapy

Abstract

Dapagliflozin was well tolerated and effective as monotherapy or combination therapy in Japanese patients with T2DM over 52 weeks.

References

YearCitations

Page 1